436 related articles for article (PubMed ID: 31493197)
1. Neuroimaging of Alzheimer's disease: focus on amyloid and tau PET.
Matsuda H; Shigemoto Y; Sato N
Jpn J Radiol; 2019 Nov; 37(11):735-749. PubMed ID: 31493197
[TBL] [Abstract][Full Text] [Related]
2. Amyloid imaging: Past, present and future perspectives.
Villemagne VL
Ageing Res Rev; 2016 Sep; 30():95-106. PubMed ID: 26827784
[TBL] [Abstract][Full Text] [Related]
3. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
Watanabe H
Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
[TBL] [Abstract][Full Text] [Related]
4. Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies.
Thal DR; Attems J; Ewers M
J Alzheimers Dis; 2014; 42 Suppl 4():S421-9. PubMed ID: 25227313
[TBL] [Abstract][Full Text] [Related]
5. Molecular imaging of dementia.
Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
[TBL] [Abstract][Full Text] [Related]
6. Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers.
Koychev I; Hofer M; Friedman N
J Nucl Med; 2020 Oct; 61(10):1413-1418. PubMed ID: 32764121
[TBL] [Abstract][Full Text] [Related]
7. Advances in the development of tau PET radiotracers and their clinical applications.
Okamura N; Harada R; Furukawa K; Furumoto S; Tago T; Yanai K; Arai H; Kudo Y
Ageing Res Rev; 2016 Sep; 30():107-13. PubMed ID: 26802556
[TBL] [Abstract][Full Text] [Related]
8. [Amyloid Positron Emission Tomography in the Therapeutic Strategies for Alzheimer's Disease].
Ishii K
Brain Nerve; 2017 Jul; 69(7):809-818. PubMed ID: 28739995
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET and amyloid-PET imaging: the diverging paths.
Perani D
Curr Opin Neurol; 2014 Aug; 27(4):405-13. PubMed ID: 24927239
[TBL] [Abstract][Full Text] [Related]
10. SPECT and PET imaging in Alzheimer's disease.
Valotassiou V; Malamitsi J; Papatriantafyllou J; Dardiotis E; Tsougos I; Psimadas D; Alexiou S; Hadjigeorgiou G; Georgoulias P
Ann Nucl Med; 2018 Nov; 32(9):583-593. PubMed ID: 30128693
[TBL] [Abstract][Full Text] [Related]
11. Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome.
Neale N; Padilla C; Fonseca LM; Holland T; Zaman S
Neuroimage Clin; 2018; 17():263-271. PubMed ID: 29159043
[TBL] [Abstract][Full Text] [Related]
12. Tau PET Imaging for Staging of Alzheimer's Disease in Down Syndrome.
Rafii MS
Dev Neurobiol; 2019 Jul; 79(7):711-715. PubMed ID: 30536948
[TBL] [Abstract][Full Text] [Related]
13. Amyloid and Tau PET Imaging of Alzheimer Disease and Other Neurodegenerative Conditions.
Rowley PA; Samsonov AA; Betthauser TJ; Pirasteh A; Johnson SC; Eisenmenger LB
Semin Ultrasound CT MR; 2020 Dec; 41(6):572-583. PubMed ID: 33308496
[TBL] [Abstract][Full Text] [Related]
14. Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease.
Prvulovic D; Hampel H
Clin Chem Lab Med; 2011 Mar; 49(3):367-74. PubMed ID: 21342022
[TBL] [Abstract][Full Text] [Related]
15. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.
Ben Bouallègue F; Mariano-Goulart D; Payoux P;
Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967
[TBL] [Abstract][Full Text] [Related]
16. AD molecular: Imaging tau aggregates with positron emissions tomography.
Betthauser TJ
Prog Mol Biol Transl Sci; 2019; 165():107-138. PubMed ID: 31481160
[TBL] [Abstract][Full Text] [Related]
17. Advanced imaging of tau pathology in Alzheimer Disease: New perspectives from super resolution microscopy and label-free nanoscopy.
Schierle GS; Michel CH; Gasparini L
Microsc Res Tech; 2016 Aug; 79(8):677-83. PubMed ID: 27324149
[TBL] [Abstract][Full Text] [Related]
18. Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions.
Villemagne VL; Doré V; Burnham SC; Masters CL; Rowe CC
Nat Rev Neurol; 2018 Apr; 14(4):225-236. PubMed ID: 29449700
[TBL] [Abstract][Full Text] [Related]
19. [Tau Positron Emission Tomography].
Higuchi M
Brain Nerve; 2017 Jul; 69(7):819-823. PubMed ID: 28739996
[TBL] [Abstract][Full Text] [Related]
20. Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease.
Roe CM; Babulal GM; Mishra S; Gordon BA; Stout SH; Ott BR; Carr DB; Ances BM; Morris JC; Benzinger TLS
J Alzheimers Dis; 2018; 61(2):509-513. PubMed ID: 29171997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
